These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11459706)

  • 1. INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES - A FIVE-YEAR SINGLE CENTER EXPERIENCE.
    Buljan D; Kranjčec I; Pavić I; Krnjaić P; Šalig S; Jakovljević G; Stepan Giljević J
    Acta Clin Croat; 2022 Dec; 61(4):647-654. PubMed ID: 37868174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Aspergillus Galactomannan Antigen Testing and the Prediction of an Outbreak during Hospital Reconstruction.
    Kaya H; Ozaki J; Okumura H
    Intern Med; 2018 Jul; 57(14):1983-1988. PubMed ID: 29526943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between a Primitive Brain Tumor and Cerebral Aspergillosis.
    Hélage S; Duyckaerts C; Seilhean D; Hauw JJ; Chiras J
    Case Rep Med; 2012; 2012():748202. PubMed ID: 22454648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
    Chabrol A; Cuzin L; Huguet F; Alvarez M; Verdeil X; Linas MD; Cassaing S; Giron J; Tetu L; Attal M; Récher C
    Haematologica; 2010 Jun; 95(6):996-1003. PubMed ID: 20007135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on antifungal treatment of invasive Candida and Aspergillus infections.
    Maschmeyer G; Ruhnke M
    Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients.
    Rupp ME; Iwen PC; Tyner LK; Marion N; Reed E; Anderson JR
    J Hosp Infect; 2008 Mar; 68(3):270-1. PubMed ID: 18226417
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus conference: Preventing the risk of Aspergillus infection in immunocompromised patients].
    Bull Cancer; 2001 Jun; 88(6):589-600. PubMed ID: 11459706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fungal infections in transplantation patients].
    Colomba C; Antinori S
    Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014.
    Chang CC; Ananda-Rajah M; Belcastro A; McMullan B; Reid A; Dempsey K; Athan E; Cheng AC; Slavin MA
    Intern Med J; 2014 Dec; 44(12b):1389-97. PubMed ID: 25482747
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.